MAXCYTE, INC. shares sold by Liontrust
- 5,194,322 shares held (5.0330%)
- Sold 81,203 shares on 01-Sep-2026 at $1.24
- Bought 138,139 shares on 14-Oct-2026 at $1.26
Liontrust Investment Partners LLP, filed by
MXCT
MAXCYTE, INC. SEC filings
Every EDGAR filing for MAXCYTE, INC. (MXCT), newest first, with AI summaries and stories.
- Ticker
- MXCT
- CIK
- 1287098
- Sector
- Biotech and pharma
- Latest filing
- 4d
Next: earnings expected ~Nov 6 · 10-Q expected ~Nov 9 (deadline Nov 16)
Filings
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
NOTABLESCHEDULE 13DMAXCYTE, INC.MXCTLIVE ROUTINE8-KMAXCYTE, INC.MXCTLIVE MaxCyte raises 2026 revenue guidance.
- Preliminary Q3 2026 revenue of $8.1M, up 26% YoY.
- SPL Program revenue of $1.0M in Q3 2026.
- Full-year 2026 revenue guidance raised to $34M from $30M-$32M.
NOTABLE10-QMAXCYTE, INC.MXCTLIVE ROUTINE8-KMAXCYTE, INC.MXCTLIVE NOTABLESCHEDULE 13DMAXCYTE, INC.MXCTLIVE Ownership stake disclosure by RIVER GLOBAL INVESTORS LLP
RIVER GLOBAL INVESTORS LLP, filed by
ROUTINESCHEDULE 13G/AMAXCYTE, INC.MXCTLIVE Ownership stake disclosure by BlackRock, Inc. (amended)
BlackRock, Inc., filed by
ROUTINE4MAXCYTE, INC.MXCTLIVE 8 insider filings
John Joseph Johnston, insider filing for MXCT
Show all 8
- 4Insider filing for MXCT
- 4Insider filing for MXCT
- 4Insider filing for MXCT
- 4Insider filing for MXCT
- 4Insider filing for MXCT
- 4Insider filing for MXCT
- 4Insider filing for MXCT
- 4Insider filing for MXCT
John Joseph Johnston, reporting
ROUTINE8-KMAXCYTE, INC.MXCTLIVE ROUTINE8-KMAXCYTE, INC.MXCTLIVE NOTABLESCHEDULE 13DMAXCYTE, INC.MXCTLIVE Ownership stake disclosure by RIVER GLOBAL INVESTORS LLP
RIVER GLOBAL INVESTORS LLP, filed by
NOTABLE10-QMAXCYTE, INC.MXCTLIVE ROUTINE8-KMAXCYTE, INC.MXCTLIVE ROUTINEARSMAXCYTE, INC.MXCTLIVE ROUTINEDEF 14AMAXCYTE, INC.MXCTLIVE ROUTINEDEFA14AMAXCYTE, INC.MXCTLIVE ROUTINE4MAXCYTE, INC.MXCTLIVE Parmeet Ahuja, insider filing for MXCT
Parmeet Ahuja, reporting
ROUTINES-8MAXCYTE, INC.MXCTLIVE ROUTINE4MAXCYTE, INC.MXCTLIVE 2 insider filings
Parmeet Ahuja, insider filing for MXCT
Show all 2
- 4Insider filing for MXCT
- 3New insider at MXCT
Parmeet Ahuja, reporting
ROUTINESCHEDULE 13G/AMAXCYTE, INC.MXCTLIVE Ownership stake disclosure by MIRABELLA FINANCIAL SERVICES LLP (amended)
MIRABELLA FINANCIAL SERVICES LLP, filed by
ROUTINE4MAXCYTE, INC.MXCTLIVE Maher Masoud, insider filing for MXCT
Maher Masoud, reporting
ROUTINE8-KMAXCYTE, INC.MXCTLIVE ROUTINESCHEDULE 13G/AMAXCYTE, INC.MXCTLIVE Ownership stake disclosure by VANGUARD GROUP INC (amended)
VANGUARD GROUP INC, filed by
NOTABLE10-KMAXCYTE, INC.MXCTLIVE ROUTINE8-KMAXCYTE, INC.MXCTLIVE ROUTINE8-KMAXCYTE, INC.MXCTLIVE ROUTINE4MAXCYTE, INC.MXCTLIVE Douglas J Swirsky, insider filing for MXCT
Douglas J Swirsky, reporting
ROUTINESCHEDULE 13G/AMAXCYTE, INC.MXCTLIVE Ownership stake disclosure by CADIAN CAPITAL MANAGEMENT, LP (amended)
CADIAN CAPITAL MANAGEMENT, LP, filed by
ROUTINESCHEDULE 13GMAXCYTE, INC.MXCTLIVE Ownership stake disclosure by Capricorn Fund Managers Ltd
Capricorn Fund Managers Ltd, filed by
ROUTINESCHEDULE 13G/AMAXCYTE, INC.MXCTLIVE Ownership stake disclosure by BlackRock, Inc. (amended)
BlackRock, Inc., filed by
ROUTINE8-KMAXCYTE, INC.MXCTLIVE ROUTINESCHEDULE 13G/AMAXCYTE, INC.MXCTLIVE Ownership stake disclosure by CADIAN CAPITAL MANAGEMENT, LP (amended)
CADIAN CAPITAL MANAGEMENT, LP, filed by
NOTABLE10-QMAXCYTE, INC.MXCTLIVE MaxCyte, Inc. (MXCT) filed its Q3 2025 quarterly report (Form 10-Q), providing investors with an update on the company's financial performance and operational activities during the period.
ROUTINE8-KMAXCYTE, INC.MXCTLIVE ROUTINE8-KMAXCYTE, INC.MXCTLIVE ROUTINESCHEDULE 13G/AMAXCYTE, INC.LIVE Ownership stake disclosure by MIRABELLA FINANCIAL SERVICES LLP (amended)
MIRABELLA FINANCIAL SERVICES LLP, filed by
ROUTINESCHEDULE 13GMAXCYTE, INC.LIVE Ownership stake disclosure by MIRABELLA FINANCIAL SERVICES LLP
MIRABELLA FINANCIAL SERVICES LLP, filed by